If a company builds assets at 20% a year, faster than its revenue growth rate of 10.2% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Maravai LifeSciences Holdings's average Total Assets Growth Rate was -47.70% per year.
During the past 3 years, the average Total Assets Growth Rate was -4.10% per year.
During the past 5 years, the average Total Assets Growth Rate was 20.00% per year.
During the past 6 years, Maravai LifeSciences Holdings's highest 3-Year average Total Assets Growth Rate was 44.00%. The lowest was -4.10%. And the median was 38.20%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maravai LifeSciences Holdings Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maravai LifeSciences Holdings (STU:MAR) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Maravai LifeSciences Holdings's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Maravai LifeSciences Holdings Total Assets Related Terms
Thank you for viewing the detailed overview of Maravai LifeSciences Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Maravai LifeSciences Holdings (STU:MAR) Business Description
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:MAR has been successfully added to your 